Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota

(Cell Metabolism 26, 672–685; October 3, 2017) Due to typographical errors in the preparation of this manuscript, several occurrences of “μg/ml” were written as “mg/ml.” In the STAR Methods section, under the heading Gut Microbiota Transplantation, the original sentence read as follows: “In brief, fresh antibiotics (1 mg/ml bacitracin, 170 mg/ml gentamycin, 125 mg/ml ciprofloxacin, 100 mg/ml neomycin, 100 U/ml penicillin, 100 mg/ml metronidazole, 100 mg/ml ceftazidime, 50 mg/ml streptomycin and 50 mg/ml vancomycin, Sigma) were added into the drinking water of mice, and changed once a week.” The actual antibiotic concentrations were as follows: 1 μg/ml bacitracin, 170 μg/ml gentamycin, 125 μg/ml ciprofloxacin, 100 μg/ml neomycin, 100 U/ml penicillin, 100 μg/ml metronidazole, 100 μg/ml ceftazidime, 50 μg/ml streptomycin and 50 μg/ml vancomycin. This has since been corrected online. Additionally, the full metagenomics dataset has now been submitted to the NCBI Sequence Read Archive (https://www.ncbi.nlm.nih.gov/sra) under the original accession number, Bioproject ID PRJNA398633. Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut MicrobiotaLi et al.Cell MetabolismSeptember 14, 2017In BriefWhite adipose beiging is a promising therapy for obesity and related metabolic diseases. Here, Li, Xie and colleagues find that an EODF regimen can selectively induce the beiging of white adipose tissue and subsequently ameliorate metabolic disorders in mice. Gut microbiota orchestrate the effects of EODF on beiging and metabolic improvement. Full-Text PDF Open Archive